Ronald R Bowsher

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

Toxins

Bioanalysis

Journal of immunoassay & immunochemistry

B2S Life Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

B2S Life Sciences Jan 01 2014

United States

Partner & CSO

Publications

Conor J Gallagher, Ronald R Bowsher, Amanda Clancy, Jeffrey S Dover, Shannon Humphrey, Yan Liu, Gregg Prawdzik
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials. Toxins 15 (1) (2023)
Conor J Gallagher, Ronald R Bowsher, Amanda Clancy, Jeffrey S Dover, Shannon Humphrey, Yan Liu, Gregg Prawdzik
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials. Toxins 15 (1) (2023)
Conor J Gallagher, Ronald R Bowsher, Amanda Clancy, Jeffrey S Dover, Shannon Humphrey, Yan Liu, Gregg Prawdzik
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials. Toxins 15 (1) (2023)
Conor J Gallagher, Ronald R Bowsher, Amanda Clancy, Jeffrey S Dover, Shannon Humphrey, Yan Liu, Gregg Prawdzik
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials. Toxins 15 (1) (2023)
Conor J Gallagher, Ronald R Bowsher, Amanda Clancy, Jeffrey S Dover, Shannon Humphrey, Yan Liu, Gregg Prawdzik
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials. Toxins 15 (1) (2023)
Jessica A Feauto, Aleks Davis, Richard C Delhaye, Sanofar J Abdeen, Hannah N Gill, Jamie E Colwell, Michael Chiappetta, Emma E Clor, Ronald R Bowsher
Critical reagent inventory management system and web portal specifically optimized for supporting external clients. Bioanalysis 14 (12) (2022)
Erica Simmons, Derrick Johnson, Richard Delhaye, Jamie Colwell, Emma Clor, Paula Santa, Ronald R Bowsher
Development and validation of a noncompetitive electrochemiluminescence-based immunoassay (ECLIA) for specific determination of insulin lispro (Humalog®) in human serum to support pharmacokinetic assessments. Journal of immunoassay & immunochemistry 40 (3) (2019)

Ronald R Bowsher.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ronald R Bowsher